Agency Forms Undergoing Paperwork Reduction Act Review, 64467-64468 [2020-22488]

Download as PDF Federal Register / Vol. 85, No. 198 / Tuesday, October 13, 2020 / Notices • Electric power, communications, and utility corridors designed for buildings and site improvements; and • Remediation of contaminated soils. Kristi Tunstall Williams, Deputy Director, Office of Planning and Design Quality, Public Buildings Service, National Capital Region, General Services Administration. [FR Doc. 2020–22605 Filed 10–9–20; 8:45 am] BILLING CODE 6820–Y1–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Agency for Healthcare Research and Quality Patient Safety Organizations (PSO): Expired Listing for FailSafe PSO Agency for Healthcare Research and Quality (AHRQ), Department of Health and Human Services (HHS). AGENCY: ACTION: Notice of delisting. The Patient Safety and Quality Improvement Final Rule (Patient Safety Rule) authorizes AHRQ, on behalf of the Secretary of HHS, to list as a patient safety organization (PSO) an entity that attests that it meets the statutory and regulatory requirements for listing. A PSO can be ‘‘delisted’’ by the Secretary if it is found to no longer meet the requirements of the Patient Safety and Quality Improvement Act of 2005 (Patient Safety Act) and Patient Safety Rule, when a PSO chooses to voluntarily relinquish its status as a PSO for any reason, or when a PSO’s listing expires. The listing for FailSafe PSO, PSO number P0196, has expired and AHRQ has delisted the PSO accordingly. SUMMARY: The delisting was effective at 12:00 Midnight ET (2400) on September 21, 2020. DATES: The directories for both listed and delisted PSOs are ongoing and reviewed weekly by AHRQ. Both directories can be accessed electronically at the following HHS website: https://www.pso.ahrq.gov/listed. ADDRESSES: khammond on DSKJM1Z7X2PROD with NOTICES FOR FURTHER INFORMATION CONTACT: Cathryn Bach, Center for Quality Improvement and Patient Safety, AHRQ, 5600 Fishers Lane, MS 06N100B, Rockville, MD 20857; Telephone (toll free): (866) 403–3697; Telephone (local): (301) 427–1111; TTY (toll free): (866) 438–7231; TTY (local): (301) 427–1130; Email: pso@ahrq.hhs.gov. SUPPLEMENTARY INFORMATION: VerDate Sep<11>2014 18:52 Oct 09, 2020 Jkt 253001 Background The Patient Safety Act, 42 U.S.C. 299b–21 to 299b–26, and the related Patient Safety Rule, 42 CFR part 3, published in the Federal Register on November 21, 2008 (73 FR 70732– 70814), establish a framework by which individuals and entities that meet the definition of provider in the Patient Safety Rule may voluntarily report information to PSOs listed by AHRQ, on a privileged and confidential basis, for the aggregation and analysis of patient safety events. The Patient Safety Act authorizes the listing of PSOs, which are entities or component organizations whose mission and primary activity are to conduct activities to improve patient safety and the quality of health care delivery. HHS issued the Patient Safety Rule to implement the Patient Safety Act. AHRQ administers the provisions of the Patient Safety Act and Patient Safety Rule relating to the listing and operation of PSOs. The Patient Safety Rule authorizes AHRQ to list as a PSO an entity that attests that it meets the statutory and regulatory requirements for listing. A PSO can be ‘‘delisted’’ if it is found to no longer meet the requirements of the Patient Safety Act and Patient Safety Rule, when a PSO chooses to voluntarily relinquish its status as a PSO for any reason, or when a PSO’s listing expires. Section 3.108(d) of the Patient Safety Rule requires AHRQ to provide public notice when it removes an organization from the list of PSOs. Section 3.104(e)(1) of the Patient Safety Rule specifies that a PSO’s listing, unless revoked or relinquished earlier, automatically expires at midnight of the last day of the threeyear listing period if, prior to this deadline, the required certifications for a new three-year listing are not submitted by the PSO and accepted by AHRQ . FailSafe PSO, a component entity of Newsura, Inc., did not seek continued listing. Accordingly, FailSafe PSO was delisted effective at 12:00 Midnight ET (2400) on September 21, 2020. More information on PSOs can be obtained through AHRQ’s PSO website at https://www.pso.ahrq.gov. Dated: October 5, 2020. Marquita Cullom-Stott, Associate Director. [FR Doc. 2020–22484 Filed 10–9–20; 8:45 am] BILLING CODE 4160–90–P PO 00000 Frm 00027 Fmt 4703 Sfmt 4703 64467 DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention [30Day–21–0910] Agency Forms Undergoing Paperwork Reduction Act Review In accordance with the Paperwork Reduction Act of 1995, the Centers for Disease Control and Prevention (CDC) has submitted the information collection request titled Message Testing for Tobacco Communication Activities (MTTCA) to the Office of Management and Budget (OMB) for review and approval. CDC previously published a ‘‘Proposed Data Collection Submitted for Public Comment and Recommendations’’ notice on February 25, 2020 to obtain comments from the public and affected agencies. CDC received two comments related to the previous notice. This notice serves to allow an additional 30 days for public and affected agency comments. CDC will accept all comments for this proposed information collection project. The Office of Management and Budget is particularly interested in comments that: (a) Evaluate whether the proposed collection of information is necessary for the proper performance of the functions of the agency, including whether the information will have practical utility; (b) Evaluate the accuracy of the agencies estimate of the burden of the proposed collection of information, including the validity of the methodology and assumptions used; (c) Enhance the quality, utility, and clarity of the information to be collected; (d) Minimize the burden of the collection of information on those who are to respond, including, through the use of appropriate automated, electronic, mechanical, or other technological collection techniques or other forms of information technology, e.g., permitting electronic submission of responses; and (e) Assess information collection costs. To request additional information on the proposed project or to obtain a copy of the information collection plan and instruments, call (404) 639–7570. Comments and recommendations for the proposed information collection should be sent within 30 days of publication of this notice to www.reginfo.gov/public/ do/PRAMain. Find this particular information collection by selecting ‘‘Currently under 30-day Review—Open E:\FR\FM\13OCN1.SGM 13OCN1 64468 Federal Register / Vol. 85, No. 198 / Tuesday, October 13, 2020 / Notices for Public Comments’’ or by using the search function. Direct written comments and/or suggestions regarding the items contained in this notice to the Attention: CDC Desk Officer, Office of Management and Budget, 725 17th Street NW, Washington, DC 20503 or by fax to (202) 395–5806. Provide written comments within 30 days of notice publication. Proposed Project Message Testing for Tobacco Communication Activities (MTTCA) (OMB Control No. 0920–0910, Exp. 05/ 31/2021)—Revision—National Center for Chronic Disease Prevention and Health Promotion (NCCDPHP), Centers for Disease Control and Prevention (CDC). Background and Brief Description Since 2012, OMB approval of a generic clearance of Message Testing for Tobacco Communication Activities (MTTCA) (OMB Control No. 0920– 0910), has been continuously maintained. CDC’s authority to collect information for public health purposes is provided by the Public Health Service Act (41 U.S.C. 241) Section 301. CDC has employed the MTTCA clearance to collect information about adult smokers’ and nonsmokers’ attitudes and perceptions, and to pretest draft messages and materials for clarity, salience, appeal, and persuasiveness. The MTTCA clearance has been used to obtain OMB approval for a variety of message testing activities, with particular emphasis on communications supporting CDC’s National Tobacco Education Campaign (NTEC) called the Tips from Former Smokers® campaign. This national campaign is designed to increase public awareness of the health consequences of tobacco use and exposure to secondhand smoke. The MTTCA clearance has also supported formative research relating to the development of health messages that are not specifically associated with the national campaign. Information collection modes under the MTTCA clearance that are supported include in-depth interviews; in-person focus groups; online focus groups; in-person, or telephone interviews; and online surveys. Each project approved under the MTTCA framework is outlined in a projectspecific Information Collection Request that describes its purpose and methodology. Messages developed from MTTCA data collection have been disseminated via multiple media channels including television, radio, print, out-of-home, and digital formats. CDC requests OMB approval to extend the MTTCA clearance, with changes, for three years. Requested changes are to increase the number of respondents and burden hours, and to expand testing of messages on non-combustible products to include heated tobacco products. These changes are needed to support CDC’s planned information collections and to accommodate additional needs that CDC may identify during the next three years. There are no changes other than adjustments to projected usage of this generic, specifically to expand message testing for additional products such as heated, non-combustible tobacco products. The MTTCA generic clearance may be used to facilitate the development of tobacco-related health communications of interest for CDC’s collaborative efforts with other federal partners including, but not limited to, the Food and Drug Administration’s Center for Tobacco Products. The MTTCA clearance does not replace the need for additional generic clearance mechanisms of HHS and other federal partners that may need to test tobacco messages related to their campaigns and initiatives. CDC is requesting increases to accommodate planned message testing needs for the NTEC as well as ad hoc testing activities that may involve other CDC/ATSDR programs. CDC will continue to use the MTTCA clearance to develop and test messages and materials using data collection methodologies including online surveys, in-person or online focus groups, and in-depth interviews. Electronic data collection methods will be employed where possible to minimize COVID–19 exposure risk. Any in-person data collection will be conducted consistent with current guidance for mitigating the risk of transmitting COVID–19. Participation is voluntary and there are no costs to respondents, other than their time. The total estimated annualized burden hours are 10,458. ESTIMATED ANNUALIZED BURDEN HOURS Number of respondents Type of respondents Form name General Public and Special Populations ........ Screening ....................................................... In-Depth Interviews (In Person) ..................... Focus Groups (In Person) ............................. Surveys (Online, Short) .................................. Surveys (Online, Medium) ............................. Surveys (In-Depth Telephone and Online) .... 36,267 67 288 36,667 2,733 1,500 khammond on DSKJM1Z7X2PROD with NOTICES Jeffrey M. Zirger, Lead, Information Collection Review Office, Office of Scientific Integrity, Office of Science, Centers for Disease Control and Prevention. [FR Doc. 2020–22488 Filed 10–9–20; 8:45 am] BILLING CODE 4163–18–P VerDate Sep<11>2014 18:52 Oct 09, 2020 Jkt 253001 PO 00000 Frm 00028 Fmt 4703 Sfmt 4703 E:\FR\FM\13OCN1.SGM 13OCN1 Number of responses per respondent 1 1 1 1 1 1 Average burden per response (in hours) 2/60 1 1.5 10/60 25/60 1

Agencies

[Federal Register Volume 85, Number 198 (Tuesday, October 13, 2020)]
[Notices]
[Pages 64467-64468]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-22488]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

[30Day-21-0910]


Agency Forms Undergoing Paperwork Reduction Act Review

    In accordance with the Paperwork Reduction Act of 1995, the Centers 
for Disease Control and Prevention (CDC) has submitted the information 
collection request titled Message Testing for Tobacco Communication 
Activities (MTTCA) to the Office of Management and Budget (OMB) for 
review and approval. CDC previously published a ``Proposed Data 
Collection Submitted for Public Comment and Recommendations'' notice on 
February 25, 2020 to obtain comments from the public and affected 
agencies. CDC received two comments related to the previous notice. 
This notice serves to allow an additional 30 days for public and 
affected agency comments.
    CDC will accept all comments for this proposed information 
collection project. The Office of Management and Budget is particularly 
interested in comments that:
    (a) Evaluate whether the proposed collection of information is 
necessary for the proper performance of the functions of the agency, 
including whether the information will have practical utility;
    (b) Evaluate the accuracy of the agencies estimate of the burden of 
the proposed collection of information, including the validity of the 
methodology and assumptions used;
    (c) Enhance the quality, utility, and clarity of the information to 
be collected;
    (d) Minimize the burden of the collection of information on those 
who are to respond, including, through the use of appropriate 
automated, electronic, mechanical, or other technological collection 
techniques or other forms of information technology, e.g., permitting 
electronic submission of responses; and
    (e) Assess information collection costs.
    To request additional information on the proposed project or to 
obtain a copy of the information collection plan and instruments, call 
(404) 639-7570. Comments and recommendations for the proposed 
information collection should be sent within 30 days of publication of 
this notice to www.reginfo.gov/public/do/PRAMain. Find this particular 
information collection by selecting ``Currently under 30-day Review--
Open

[[Page 64468]]

for Public Comments'' or by using the search function. Direct written 
comments and/or suggestions regarding the items contained in this 
notice to the Attention: CDC Desk Officer, Office of Management and 
Budget, 725 17th Street NW, Washington, DC 20503 or by fax to (202) 
395-5806. Provide written comments within 30 days of notice 
publication.

Proposed Project

    Message Testing for Tobacco Communication Activities (MTTCA) (OMB 
Control No. 0920-0910, Exp. 05/31/2021)--Revision--National Center for 
Chronic Disease Prevention and Health Promotion (NCCDPHP), Centers for 
Disease Control and Prevention (CDC).

Background and Brief Description

    Since 2012, OMB approval of a generic clearance of Message Testing 
for Tobacco Communication Activities (MTTCA) (OMB Control No. 0920-
0910), has been continuously maintained. CDC's authority to collect 
information for public health purposes is provided by the Public Health 
Service Act (41 U.S.C. 241) Section 301.
    CDC has employed the MTTCA clearance to collect information about 
adult smokers' and nonsmokers' attitudes and perceptions, and to 
pretest draft messages and materials for clarity, salience, appeal, and 
persuasiveness. The MTTCA clearance has been used to obtain OMB 
approval for a variety of message testing activities, with particular 
emphasis on communications supporting CDC's National Tobacco Education 
Campaign (NTEC) called the Tips from Former Smokers[supreg] campaign. 
This national campaign is designed to increase public awareness of the 
health consequences of tobacco use and exposure to secondhand smoke. 
The MTTCA clearance has also supported formative research relating to 
the development of health messages that are not specifically associated 
with the national campaign.
    Information collection modes under the MTTCA clearance that are 
supported include in-depth interviews; in-person focus groups; online 
focus groups; in-person, or telephone interviews; and online surveys. 
Each project approved under the MTTCA framework is outlined in a 
project-specific Information Collection Request that describes its 
purpose and methodology. Messages developed from MTTCA data collection 
have been disseminated via multiple media channels including 
television, radio, print, out-of-home, and digital formats.
    CDC requests OMB approval to extend the MTTCA clearance, with 
changes, for three years. Requested changes are to increase the number 
of respondents and burden hours, and to expand testing of messages on 
non-combustible products to include heated tobacco products. These 
changes are needed to support CDC's planned information collections and 
to accommodate additional needs that CDC may identify during the next 
three years. There are no changes other than adjustments to projected 
usage of this generic, specifically to expand message testing for 
additional products such as heated, non-combustible tobacco products. 
The MTTCA generic clearance may be used to facilitate the development 
of tobacco-related health communications of interest for CDC's 
collaborative efforts with other federal partners including, but not 
limited to, the Food and Drug Administration's Center for Tobacco 
Products. The MTTCA clearance does not replace the need for additional 
generic clearance mechanisms of HHS and other federal partners that may 
need to test tobacco messages related to their campaigns and 
initiatives.
    CDC is requesting increases to accommodate planned message testing 
needs for the NTEC as well as ad hoc testing activities that may 
involve other CDC/ATSDR programs. CDC will continue to use the MTTCA 
clearance to develop and test messages and materials using data 
collection methodologies including online surveys, in-person or online 
focus groups, and in-depth interviews. Electronic data collection 
methods will be employed where possible to minimize COVID-19 exposure 
risk. Any in-person data collection will be conducted consistent with 
current guidance for mitigating the risk of transmitting COVID-19. 
Participation is voluntary and there are no costs to respondents, other 
than their time. The total estimated annualized burden hours are 
10,458.

                                        Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
                                                                                     Number of    Average burden
        Type of respondents                   Form name              Number of     responses per   per response
                                                                    respondents     respondent      (in hours)
----------------------------------------------------------------------------------------------------------------
General Public and Special           Screening..................          36,267               1            2/60
 Populations.                        In-Depth Interviews (In                  67               1               1
                                      Person).
                                     Focus Groups (In Person)...             288               1             1.5
                                     Surveys (Online, Short)....          36,667               1           10/60
                                     Surveys (Online, Medium)...           2,733               1           25/60
                                     Surveys (In-Depth Telephone           1,500               1               1
                                      and Online).
----------------------------------------------------------------------------------------------------------------


Jeffrey M. Zirger,
Lead, Information Collection Review Office, Office of Scientific 
Integrity, Office of Science, Centers for Disease Control and 
Prevention.
[FR Doc. 2020-22488 Filed 10-9-20; 8:45 am]
BILLING CODE 4163-18-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.